Lars Erik Steinkjer, Nora Bratheim and Guro S. Kyrkjebø Nybø have contributed to the Norwegian chapter in the Chambers and Partners Life Sciences & Pharma IP Litigation 2024 Global Practice Guide.

Wikborg Rein is a contributing firm to the Life Science & Pharma IP Litigation 2023 with Chambers and Partners.

Update on the implementation of the SPC manufacturing waiver for pharmaceutical manufacturers into Norwegian law.

Russia has announced and implemented several countermeasures against so-called "unfriendly states". Some of these countermeasures involve intellectual property rights (IPR), meaning that entities of so-called "unfriendly states" now face countermeasures limiting the protection of their IPR in Russia. Entities of such states that do not anticipate continuing to do business in Russia can expect to see their intellectual property utilised in Russia without compensation.

Recent developments bring the new Unified Patent Court (UPC) closer to reality. This means that companies doing business in the EU should start considering whether they want to engage with the new UPC system or not.

In a decision published 20 March, the German Constitutional Court declared the vote on the ratification act of the Unified Patent Court (UPC) Agreement void because the German Parliament did not pass the act with the required majority. The decision is published less than one month after the UK said it would not be seeking involvement in the system, and further support the growing speculations that the UPC will never get off the ground.

Consumer, marketing and e-commerce

Life sciences and healthcare

Intellectual Property

International Trade

Dispute Resolution

Managing Associate

Nora works with Intellectual Property Law (including patents, trademarks, design, trade secrets and copyright) and marketing law. Her expertise also encompasses regulatory requirements within life science and consumer goods. 

Nora frequently represents clients before the courts and has experience with complex international disputes. She also has experience with representing clients before other dispute resolution institutions and public authorities, including proceedings before the Industrial Property Office and the Norwegian Board of Appeal for Industrial Property Rights. 

Nora's field of expertise also encompasses legal regulations on confidentiality and Freedom of Information. She has previously worked in the Legislation Department of the Ministry of Justice within intellectual property law, EEA/EU law and administrative law. At the Ministry of Justice, Nora worked with questions related to trade secrets, sharing of information, right to information, confidentiality obligations and non-disclosure exemption of confidential evidence. 

In 2023 and 2024, Nora was ranked, being the only one in Norway, as an "Associate to watch" in the category "Intellectual Property" by Chambers and Partners, and she is ranked as a "Rising star" by Legal 500 and by Managing Intellectual Property (IP Stars).

"She is always available and very solution oriented" - Chambers Europe, 2023 

"Nora has a very good technical understanding and is strong in looking at the bigger picture." - Chambers Europe, 2024

Oslo

Editor, EPLAW patent blog

Member of the Committee of NIR Ung

Trainee Committee, Wikborg Rein

{"title":{"title":"Nora Bratheim | Wikborg Rein"}}

Nora works with Intellectual Property Law (including patents, trademarks, design, trade secrets and copyright) and marketing law.